David Milligan, M.D. Net Worth & Insider Trades

David Milligan, M.D. - Director, Madrigal Pharmaceuticals, Inc

As of June 21, 2022

What is David Milligan, M.D.'s Net Worth?

The current estimated net worth of Madrigal Pharmaceuticals, Inc's Director, David Milligan, M.D., is estimated to be about $5.05M . David Milligan, M.D. owns about 20,000 units of Madrigal Pharmaceuticals, Inc common stock. In the last 5 years at Madrigal Pharmaceuticals, Inc, David Milligan, M.D. has sold an estimated value of $3.57M worth.

What is David Milligan, M.D.'s Past Insider Trading?

David Milligan, M.D.'s largest sale order was 20,000 units , worth over $2.25M on February 26, 2020. In total, David Milligan, M.D. has made about 9 transactions over 5 years of their time at Madrigal Pharmaceuticals, Inc. David Milligan, M.D. usually trades in June, with the busiest year in 2020 and 2018. The most recent transaction was a sale order of 10,000 units , worth over $1.32M on February 26, 2020.

David Milligan, M.D.

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Milligan, M.D.'s' Mailing Address?

  • Mailing address is 801 Interlaken Ln. Libertyville IL 60048 IL

Madrigal Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Bonus
Other Compensation
Total
Paul A. Friedman, M.D. 2020 $603,500 $3,468,500 $463,446 - - $4,535,446
Paul A. Friedman, M.D. 2019 $584,000 $5,122,000 $387,192 - - $6,093,192
Paul A. Friedman, M.D. 2018 $416,666 $4,907,500 $304,500 - - $5,628,666
Rebecca Taub, M.D. 2020 $490,833 $3,052,280 $339,230 - - $3,882,343
Rebecca Taub, M.D. 2019 $463,948 $4,531,120 $274,775 - - $5,269,843
Rebecca Taub, M.D. 2018 $385,416 $3,729,700 $225,330 - - $4,340,446
Remy Sukhija 2020 $337,500 $2,724,000 $274,680 $100,000 $2,722 $3,438,902
Marc R. Schneebaum 2020 $435,000 $2,219,840 $267,233 - $18,399 $2,940,472
Marc R. Schneebaum 2019 $421,000 $2,868,320 $223,298 - $20,034 $3,532,652
Marc R. Schneebaum 2018 $380,250 $2,748,200 $222,314 - $15,336 $3,366,100
Brian J. Lynch 2020 $425,417 $3,749,840 $260,946 - $11,690 $4,447,893
Brian J. Lynch 2019 $358,602 $3,506,859 $192,602 - $10,574 $4,068,637
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1157601/000119312521144922/d107927ddef14a.htm

What are Madrigal Pharmaceuticals, Inc's Past Insider Trades?

Madrigal Pharmaceuticals, Inc's most recent insider trade came on August 19, 2020 by Bay City Capital Llc, Bay City Capital Management Iv Llc, Bay City Capital Fund Iv Lp and Bay City Capital Fund Iv Co Invesment Fund Lp who sold 30,000 units worth $3.29M . In the last 3 years, insiders at Madrigal Pharmaceuticals, Inc have sold an estimated value of $446.89M and bought an estimated value of $25.24M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Fred B Craves, Director,  David Milligan, M.D., Director,  and Paul Friedman, Chief Executive Officer .

MADRIGAL PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1